LZTS1 anticorps (AA 47-212) (HRP)

N° du produit ABIN7158029

Détail du produit anti-LZTS1 anticorps (HRP)

Antigène: LZTS1 (Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1))

Épitope: AA 47-212

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LZTS1 est conjugé à/à la HRP

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Leucine zipper putative tumor suppressor 1 protein (47-212AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur LZTS1

Antigène: LZTS1 (Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1))

Autre désignation: LZTS1 (LZTS1 Produits)

Synonymes: anticorps F37, anticorps FEZ1, anticorps Psdzip70, anticorps LZTS1, anticorps f37, anticorps fez1, anticorps leucine zipper tumor suppressor 1, anticorps leucine zipper, putative tumor suppressor 1, anticorps LZTS1, anticorps Lzts1, anticorps lzts1

Sujet:

Background: Involved in the regulation of cell growth. May stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. May act as a tumor suppressor.

Aliases: F37 antibody, F37/esophageal cancer related gene coding leucine zipper motif antibody, F37/esophageal cancer-related gene-coding leucine-zipper motif antibody, Fez1 antibody, Leucine zipper putative tumor suppressor 1 antibody, Lzts1 antibody, LZTS1_HUMAN antibody, Psdzip70 antibody

UniProt: Q9Y250

Pathways: Synaptic Membrane